|
Jul 29
|
HLS Announces Reimbursement for Vascepa® under Alberta's Provincial Drug Plan
|
|
Jul 25
|
HLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference Call
|
|
Feb 6
|
HLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug Plan
|
|
Dec 18
|
HLS Therapeutics Announces CFO Departure
|
|
Dec 5
|
HLS Therapeutics (TSE:HLS) shareholders have endured a 78% loss from investing in the stock three years ago
|
|
Aug 10
|
HLS Therapeutics Announces Q2 Fiscal 2023 Financial Results
|
|
Jun 22
|
HLS Therapeutics Announces Updates to its Board of Directors
|
|
May 3
|
HLS Therapeutics to Host Q1 Fiscal 2023 Financial Results Conference Call
|